Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Congleton Jon sold 75,000 Mineralys Therapeutics, Inc. shares (Form 4)

Traded Jun 30, 2026 · Filed Jun 30, 2026

On Jun 30, 2026, Congleton Jon (Director, Chief Executive Officer) sold 75,000 Mineralys Therapeutics, Inc. shares at an average US$26.14 for US$1.96M under a trading plan, leaving 614,321 shares. Filed Jun 30, 2026 (Form 4).

Sold
75,000 shares
Price
US$26.14 average (US$25.94 to US$26.82)
Value
US$1.96M
Holding after
614,321 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common StockSale58,000US$25.94631,321Direct
Jun 30, 2026Common StockSale17,000US$26.82614,321Direct

Source

View original at SEC

Related